Hologic’s latest update keeps its fair value estimate steady at about US$76.60 per share, signaling no change to the headline price target in current analyst models. That stability comes as research ...
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (VNRX) (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with ...
Company Kicks Off October by Ringing Nasdaq Opening Bell, Releasing Educational Resources for Women MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s ...
Hologic HOLX operates across four segments, but investor attention last year remained particularly heightened on the Breast Health business. From expected gantry slowdowns impacting sales to improved ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it has been awarded a $19 million contract from the Biomedical Advanced Research and Development Authority (BARDA ...
As Hologic gears up to cease operations at its Danbury, Connecticut facility in December, the Marlborough-based medical device manufacturer plans tol incrementally lay off 86 employees by the end of ...
-- Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Segments and Geography – MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global ...
A Cervical Cancer Awareness Month campaign from over 30 women’s health brands led by Teal Health wasn’t the only such effort launched during January. Another came out of medtech firm Hologic, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results